قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ A quantitative approach to measuring the reservoir of latent HIV-1 proviruses

A quantitative approach to measuring the reservoir of latent HIV-1 proviruses



  • first Finzi, D. et al. Identification of a reservoir for HIV-1 in patients with highly active antiretroviral therapy. 278 1295-1300 (1997).

  • 2nd Chun, T. W. et al. Presence of an inducible HIV-1
    latent reservoir under highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA 94 13193-13197 (1997).

  • 3rd Wong, J. K. et al. Recovery of replication competent HIV despite prolonged suppression of plasma viremia. 278 1291-1295 (1997).

  • 4th

    Archin, N. M. et al. Administration of vorinostat interferes with HIV-1 latency in patients receiving antiretroviral therapy. 487 482-485 (2012).

  • 5th Borducchi, E. N. et al. Ad26 / MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature 540 284-287 (2016).

  • 6th Procopio, F. A. et al. A new assay for measuring the size of the inducible viral reservoir of HIV-infected individuals. EBioMedicine 2 874-883 (2015).

  • 7th Ho, Y.C. et al. Replication-competent non-induced proviruses in the latent reservoir increase the barrier to HIV-1 cure. 155 540-551 (2013).

  • 8 thereof. Bruner, K. M. et al. Defective proviruses accumulate rapidly during acute HIV-1 infection. Nat. With . 22 1043-1049 (2016).

  • ninth Imamichi, H. et al. Defective HIV-1 proviruses produce new protein coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc. Natl Acad. Sci. USA 113 8783-8788 (2016).

  • 10th

    Sheehy, AM, Gaddis, NC, Choi, JD & Malim, MH Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 646-650 (2002).

  • eleventh

    Jordan, A., Bisgrove, D. & amp; Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J . 1868-1877 (2003).

  • 12th Finzi, D. et al. Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients with effective combination therapy. Nat. With . 512-517 (1999).

  • thirteenth Crooks, A. M. et al. Precise quantification of latent HIV-1 reservoir: effects on eradication strategies. J. Infection. That's . 212 1361-1365 (2015).

  • fourteenth

    Maldarelli, F. et al. Specific HIV integration sites are associated with clonal expansion and sustained cell infection. Science 345 179-183 (2014).

  • 15th Wagner, T. A. et al. Spreading cells with HIV integrated into cancer genes contributes to persistent infection. Science 345 570-573 (2014).

  • 16th Bui, J. K. et al. Viruses with identical sequences comprise a large portion of the replication competent HIV reservoir. PLoS Pathog . e1006283 (2017).

  • 17th Lorenzi, J.C. et al. Paired quantitative and qualitative assessment of the replication competent HIV-1 reservoir and comparison with integrated proviral DNA. Proc. Natl Acad. Sci. USA 113 E7908-E7916 (2016).

  • 18th Hosmane, N. N. et al. Spread of Latently Infected CD4 + T-cells bearing replication-competent HIV-1: potential role in latent reservoir dynamics. J. Exp. With . 214 959-972 (2017).

  • 19th [1965] Wang, Z. et al. Extended cellular clones carrying replication-competent HIV-1 persist, grow and decline. Proc. Natl Acad. Sci. USA 115 E2575-E2584 (2018).

  • 20th Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. With . 893-900 (2009).

  • 21st

    Cohn, L. B. et al. HIV-1 integration landscape during latent and active infection. 160 420-432 (2015).

  • 22nd Ho, D. D. et al. Rapid reaction of plasma virions and CD4 lymphocytes into HIV-1 infection. 373 123-126 (1995).

  • 23rd Wei, X. et al. Viral dynamics of human immunodeficiency virus type 1 infection. 373 117-122 (1995).

  • 24th Simonetti, F.R. et al. Clonally Expanded CD4 + [T cells] can produce infectious HIV-1 in vivo. Proc. Natl Acad. Sci. USA 113 1883-1888 (2016).

  • 25th Pollack, R. A. et al. Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes that form the proviral landscape. Cell Host Microbe 21 494-506 (2017).

  • 26th Berry, C. C. et al. Estimation of surfaces of retroviral insertion sites from DNA fragment length data. Bioinformatics 28 755-762 (2012).

  • 27th Detels, R. et al. The multicenter AIDS Cohort Study, 1983 for … Public Health 126 196-198 (2012).

  • 28th

    Rose, PP & Korber, BT Detection of hypermutations in virus sequences with a weight of G → A hypermutation. Bioinformatics 400-401 (2000).

  • 29th

    Laird, GM, Rosenbloom, DI, Lai, J., Siliciano, RF & Siliciano, JD Measurement of the rate of latent HIV-1 in resting CD4 + T cells using a limiting dilution culture culture assay . Methods Mol. Biol . 1354 239-253 (2016).

  • 30th

    Laird, G. M. et al. Rapid quantitation of the latency reservoir for HIV-1 using a virus outgrowth assay. PLoS Pathog . 9 e1003398 (2013).

  • 31 December.

    Rosenbloom, D. I. et al. Design and interpretation of limiting dilution assays: general principles and applications for latent reservoir of human immunodeficiency virus-1. Open Forum Infect. That's . 2 ofv123 (2015).

  • 32nd

    Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subgroups of memory T lymphocytes with different homing potentials and effector functions. 401 708-712 (1999).

  • 33rd

    Durand, C. M. et al. HIV-1 DNA is detected in bone marrow populations containing CD4 + T cells, but is not found in purified CD34 + hematopoietic stem cells in most patients on antiretroviral therapy. J. Infection. That's . 205 1014-1018 (2012).

  • 34th Lewinski, M. K. et al. Continuous analysis of chromosomal features suppression of human immunodeficiency virus transcription. J. Virol . 79 6610-6619 (2005).

  • 35th Sherman, E. et al. INSPIIRED: A pipeline for quantitative analysis of sites for new DNA integration into cellular genomes. Mol. Ther. Methods Clin. Dev . 39-49 (2017).


  • Source link